CSIMarket
 
Elanco Animal Health Incorporated  (NYSE: ELAN)
 

Elanco Animal Health Incorporated's Customers Performance

ELAN



 
ELAN's Source of Revenues During the corresponding time, Elanco Animal Health Incorporated recorded a revenue increase by 10.23 % year on year, sequentially revenue fell by -0.22 %. While revenue at the Elanco Animal Health Incorporated's corporate clients

List of ELAN Customers




for the same period Elanco Animal Health Incorporated recorded revenue increase by 10.23 % year on year, sequentially revenue fell by -0.22 %.

List of ELAN Customers

Elanco Animal Health Incorporated's Business Units
Pet Health    104.39 % of total Revenue
Cattle    45.98 % of total Revenue
Poultry    33.11 % of total Revenue
Swine    14.11 % of total Revenue
Farm Animal    93.2 % of total Revenue
Contract Manufacturing    2.63 % of total Revenue
United States    92.69 % of total Revenue
Non-US    107.53 % of total Revenue
Reportable    200.22 % of total Revenue






Elanco Animal Health Incorporated's Comment on Sales, Marketing and Customers



The company operates within the animal health industry, serving customers involved in the care of animals across multiple species, primarily focusing on pet health (dogs and cats) and farm animal health (cattle, poultry, swine, and sheep). Its products are distributed in over 90 countries. The company targets market segments including pet health and farm animal health, supporting producers, veterinarians, pet owners, and consumers. It operates as a single segment with a comprehensive portfolio for both pet and farm animal health. The company emphasizes innovation, portfolio expansion, and productivity to drive revenue and profitability growth, leveraging established customer relationships and expanding geographic and channel reach. Customers and markets referenced in company filings include Bayer Animal Health, Eli Lilly and Company, and Lilly.


  News about Elanco Animal Health Incorporated Contracts

Delays in Product Launches Raise Concerns for Elanco Animal Health (ELAN) as Investor Losses Mount

Elanco Animal Health (ELAN) Faces Scrutiny Over Delayed Pr...




Elanco Animal Health Incorporated’s Comment on Sales, Marketing and Customers


The company operates within the animal health industry, serving customers involved in the care of animals across multiple species, primarily focusing on pet health (dogs and cats) and farm animal health (cattle, poultry, swine, and sheep). Its products are distributed in over 90 countries. The company targets market segments including pet health and farm animal health, supporting producers, veterinarians, pet owners, and consumers. It operates as a single segment with a comprehensive portfolio for both pet and farm animal health. The company emphasizes innovation, portfolio expansion, and productivity to drive revenue and profitability growth, leveraging established customer relationships and expanding geographic and channel reach. Customers and markets referenced in company filings include Bayer Animal Health, Eli Lilly and Company, and Lilly.








ELAN's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Elanco Animal Health Incorporated 11,564.87 4,893.00 -242.00 9,900
SUBTOTAL 0.00 0.00 0.00 -

Sources: Elanco Animal Health Incorporated’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Elanco Animal Health Incorporated’s corporate clients.
For your research, we’ve provided 9 tables on Elanco Animal Health Incorporated corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.